A
Amy Jewett
Researcher at Oak Ridge Institute for Science and Education
Publications - 11
Citations - 1269
Amy Jewett is an academic researcher from Oak Ridge Institute for Science and Education. The author has contributed to research in topics: Hepatitis C & Population. The author has an hindex of 8, co-authored 9 publications receiving 1175 citations.
Papers
More filters
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
Bryce D. Smith,Rebecca L. Morgan,Geoff A. Beckett,Yngve Falck-Ytter,Deborah Holtzman,Chong-Gee Teo,Amy Jewett,Brittney Baack,David B. Rein,Nita Patel,Miriam J. Alter,Anthony Yartel,John W. Ward +12 more
TL;DR: Targeted testing and linkage to care for infected persons in this birth cohort is expected to reduce HCV-related morbidity and mortality and help halt disease progression and provide a virologic cure.
Journal ArticleDOI
Evaluation of Three Rapid Screening Assays for Detection of Antibodies to Hepatitis C Virus
Bryce D. Smith,Jan Drobeniuc,Amy Jewett,Bernard M. Branson,Richard S. Garfein,Eyasu H. Teshale,Saleem Kamili,Cindy M. Weinbaum +7 more
TL;DR: Rapid anti- HCV tests can provide sensitive and specific anti-HCV results for high-risk patients and are associated with human immunodeficiency virus positivity for both approaches for Chembio and MedMira.
Journal ArticleDOI
Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
Bryce D. Smith,Eyasu H. Teshale,Amy Jewett,Cindy M. Weinbaum,Alan Neaigus,Holly Hagan,Samuel M. Jenness,Sharon K. Melville,Richard D. Burt,Hanne Thiede,Alia Al-Tayyib,Praveen R. Pannala,IIsa W. Miles,Alexa M. Oster,Amanda Smith,Teresa Finlayson,Kristina E. Bowles,Elizabeth DiNenno +17 more
TL;DR: Sitive rapid anti-HCV assays are appropriate and feasible for high-prevalence, high-risk populations such as PWID, who can be reached through social service settings such as syringe exchange programs and methadone maintenance treatment programs.
Journal ArticleDOI
Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA
Amy Jewett,Bryce D. Smith,Richard S. Garfein,Jazmine Cuevas-Mota,Eyasu H. Teshale,Cindy M. Weinbaum +5 more
TL;DR: Sensitive anti-HCV rapid assays are appropriate and feasible for high-prevalence, high-risk populations such as young PWID and are associated with female sex for the MedMira blood assay.
Journal ArticleDOI
“To Share or Not to Share?” Serosorting by Hepatitis C Status in the Sharing of Drug Injection Equipment Among NHBS-IDU2 Participants
TL;DR: Injection equipment serosorting-considering HCV serostatus when deciding whether and with whom to share injection equipment is examined, suggesting PWID are more likely to sharejection equipment with persons of concordant HCV status.